메뉴 건너뛰기




Volumn 18, Issue 1, 2003, Pages 106-112

Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients

Author keywords

C reactive protein; Folic acid; Haemodialysis; Homocysteine; Mortality; Oxidized LDL antibodies

Indexed keywords

ACFOL; BENEXOL; C REACTIVE PROTEIN; FOLIC ACID; HOMOCYSTEINE; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; VITAMIN B COMPLEX;

EID: 12244307891     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.1.106     Document Type: Article
Times cited : (106)

References (25)
  • 1
    • 0031471941 scopus 로고    scopus 로고
    • Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
    • Bostom AG, Shemin D, Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 1997; 17: 2554-2558
    • (1997) Arterioscler. Thromb. Vasc. Biol. , vol.17 , pp. 2554-2558
    • Bostom, A.G.1    Shemin, D.2    Verhoef, P.3
  • 2
    • 0034816582 scopus 로고    scopus 로고
    • Treatment of hyperhomocysteinemia in end-stage renal disease
    • Shemin D, Bostom A, Selhub J. Treatment of hyperhomocysteinemia in end-stage renal disease. Am J Kidney Dis 2001; 38: S91-S94
    • (2001) Am. J. Kidney Dis. , vol.38
    • Shemin, D.1    Bostom, A.2    Selhub, J.3
  • 3
    • 0033554459 scopus 로고    scopus 로고
    • Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
    • Kanani P, Sinkey C, Browning R, Allaman M, Knapp H, Haynes W. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999; 100: 1161-1168
    • (1999) Circulation , vol.100 , pp. 1161-1168
    • Kanani, P.1    Sinkey, C.2    Browning, R.3    Allaman, M.4    Knapp, H.5    Haynes, W.6
  • 4
    • 0028210390 scopus 로고
    • Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
    • Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994; 45: 876-883
    • (1994) Kidney Int. , vol.45 , pp. 876-883
    • Maggi, E.1    Bellazzi, R.2    Falaschi, F.3
  • 5
    • 0026333959 scopus 로고
    • Role of oxidised low density lipoprotein in atherogenesis
    • Witztum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792
    • (1991) J. Clin. Invest. , vol.88 , pp. 1785-1792
    • Witztum, J.L.1    Steinberg, D.2
  • 7
    • 0034783872 scopus 로고    scopus 로고
    • Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia
    • Mezzano D, Pais EO, Aranda E et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001; 60: 1844-1850
    • (2001) Kidney Int. , vol.60 , pp. 1844-1850
    • Mezzano, D.1    Pais, E.O.2    Aranda, E.3
  • 10
    • 0035163912 scopus 로고    scopus 로고
    • Homocysteine and lipid peroxidation in haemodialysis: Role of folic acid and vitamin E
    • Bayés B, Pastor MC, Bonal J, Juncà J, Romero R. Homocysteine and lipid peroxidation in haemodialysis: role of folic acid and vitamin E. Nephrol Dial Transplant 2001; 16: 2172-2175
    • (2001) Nephrol. Dial. Transplant , vol.16 , pp. 2172-2175
    • Bayés, B.1    Pastor, M.C.2    Bonal, J.3    Juncà, J.4    Romero, R.5
  • 11
    • 0035116514 scopus 로고    scopus 로고
    • Autoantibodies to oxidised low-density lipoprotein in coronary artery disease
    • Sherer Y, Tenenbaum A, Blank M et al. Autoantibodies to oxidised low-density lipoprotein in coronary artery disease. Am J Hypertens 2001; 14: 149-154
    • (2001) Am. J. Hypertens. , vol.14 , pp. 149-154
    • Sherer, Y.1    Tenenbaum, A.2    Blank, M.3
  • 12
    • 0031914677 scopus 로고    scopus 로고
    • Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
    • Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141
    • (1998) Circulation , vol.97 , pp. 138-141
    • Moustapha, A.1    Naso, A.2    Nahlawi, M.3
  • 13
    • 0036153990 scopus 로고    scopus 로고
    • On behalf of the CRREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
    • Mallamaci F, Zoccali C, Tripepi G et al. on behalf of the CRREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614
    • (2002) Kidney Int. , vol.61 , pp. 609-614
    • Mallamaci, F.1    Zoccali, C.2    Tripepi, G.3
  • 14
    • 0033533527 scopus 로고    scopus 로고
    • Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
    • Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375
    • (1999) Ann. Intern. Med. , vol.131 , pp. 363-375
    • Eikelboom, J.W.1    Lonn, E.2    Genest J., Jr.3    Hankey, G.4    Yusuf, S.5
  • 15
  • 16
    • 0034033115 scopus 로고    scopus 로고
    • Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
    • Suliman ME, Qureshi AR, Barany P et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 2000; 57: 1727-1735
    • (2000) Kidney Int. , vol.57 , pp. 1727-1735
    • Suliman, M.E.1    Qureshi, A.R.2    Barany, P.3
  • 17
    • 0032914427 scopus 로고    scopus 로고
    • Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
    • Voutilainen S, Morrow J, Roberts J et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999; 19: 1263-1266
    • (1999) Arterioscler. Thromb. Vasc. Biol. , vol.19 , pp. 1263-1266
    • Voutilainen, S.1    Morrow, J.2    Roberts, J.3
  • 18
    • 0034702916 scopus 로고    scopus 로고
    • Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
    • Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000; 102: 871-875
    • (2000) Circulation , vol.102 , pp. 871-875
    • Thambyrajah, J.1    Landray, M.J.2    McGlynn, F.J.3    Jones, H.J.4    Wheeler, D.C.5    Townend, J.N.6
  • 19
    • 0036095165 scopus 로고    scopus 로고
    • 5-Methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis
    • Buccianti G, Raselli S, Baragetti I et al. 5-Methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol Dial Transplant 2002; 17: 857-864
    • (2002) Nephrol. Dial. Transplant , vol.17 , pp. 857-864
    • Buccianti, G.1    Raselli, S.2    Baragetti, I.3
  • 20
    • 0035107609 scopus 로고    scopus 로고
    • Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
    • Hofmann MA, Lalla E, Lu Y et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001; 107: 675-683
    • (2001) J. Clin. Invest. , vol.107 , pp. 675-683
    • Hofmann, M.A.1    Lalla, E.2    Lu, Y.3
  • 22
    • 0032952901 scopus 로고    scopus 로고
    • Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
    • Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
    • (1999) Kidney Int. , vol.55 , pp. 1899-1911
    • Stenvinkel, P.1    Heimbürger, O.2    Paultre, F.3
  • 23
    • 0036118126 scopus 로고    scopus 로고
    • Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
    • Holven K, Aukrust P, Holm T, Ose L, Nenseter M. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002; 22: 699-703
    • (2002) Arterioscler. Thromb. Vasc. Biol. , vol.22 , pp. 699-703
    • Holven, K.1    Aukrust, P.2    Holm, T.3    Ose, L.4    Nenseter, M.5
  • 24
    • 0033789815 scopus 로고    scopus 로고
    • Circulating oxidised low density lipoprotein levels. A biochemical risk marker for coronary heart disease
    • Toshima S, Hasegawa A, Kurabayashi M et al. Circulating oxidised low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243-2247
    • (2000) Arterioscler. Thromb. Vasc. Biol. , vol.20 , pp. 2243-2247
    • Toshima, S.1    Hasegawa, A.2    Kurabayashi, M.3
  • 25
    • 0035901582 scopus 로고    scopus 로고
    • Elevated levels of oxidised low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
    • Ehara S, Ueda M, Naruko T et al. Elevated levels of oxidised low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955-1960
    • (2001) Circulation , vol.103 , pp. 1955-1960
    • Ehara, S.1    Ueda, M.2    Naruko, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.